Delivery Order SPE2DB24D1104-SPE2DB25FYDL8
- Not listed
- The Defense Logistics Agency (DLA) awarded a $21,320.61 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Erleada 240 mg tablets. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has a completion date of August 6, 2024 and...
- This is a $14,704.98 delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ERLEADA 240 MG TABLET UU 30S. The contract has an ultimate completion date of July 29, 2025 and is a firm fixed price agreement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health Agency and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,352.49 firm fixed-price contract is for the delivery of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product, with a period of performance ending on June 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price contract is for the supply of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The contract has a period of performance through February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of ERLEADA 60 MG TABLET UU 120S. The order has a potential value of $34,838.56 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing pharmaceuticals and medical supplies to U.S. government agencies, primarily the Department of...
- The U.S. Defense Logistics Agency (DLA) awarded a $29,225.12 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of 4,565,439,067 units of the pharmaceutical product ERLEADA 60 MG TABLET with a completion date of September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medical commodities to support military treatment facilities and other federal healthcare...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading pharmaceutical distributor, for the supply of the drug Erleada (60 mg tablets) valued at $7,106.87. The award has an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor on this delivery order, which does not have a set-aside designation. The company also holds a...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,106.87 firm fixed price delivery order is for the medication Erleada 60 mg tablet and has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ERLEADA 240 MG TABLET UU 30S. The contract has a firm fixed price of $7,352.49 and a period of performance through June 5, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,704.98 firm-fixed-price delivery order is for the supply of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYDL8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,117.58 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets in quantities of 120 units. This non-competitive, firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, holds a substantial $999.999 billion IDC with DLA running through December 2026, which serves as the contracting vehicle for this and similar pharmaceutical deliveries to support military and federal healthcare systems globally. The parent IDC encompasses a comprehensive range of pharmaceutical products, specialty medications, vaccines, and medical supplies across multiple therapeutic domains, enabling the company to supply the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies AmerisourceBergen's role as a key pharmaceutical provider within the federal medical supply chain, delivering critical medications to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 7/18/25 |